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this paper aims to assess the usability and advantages of three-dimensional rotational angiography 
(3DRA) in patients with congenital heart disease (CHD) and its application in the cath lab. Up to now, 
its use in CHD is not widespread or standardized. We analyzed all patients with CHD who underwent 
a 3DRA at our facility between January 2010 and May 2019. The 3DRAs were evaluated for radiation 
exposure, contrast dye consumption, diagnostic utility and image quality. We performed 872 3DRAs. 
3DRA was used in 67.1% of the cases for interventional procedures and in 32.9% for diagnostic 
purposes. Two different acquisition programs were applied. The median dose-area product (DAP) for all 
872 rotations was 54.1 µGym2 (21.7–147.5 µGym2) and 1.6 ml/kg (0.9–2.07 ml/kg) of contrast dye was 
used. Diagnostic utility of the generated 3D-model was rated superior to the native 3D angiography 
in 94% (819/872). 3DRA is an excellent and save diagnostic and interventional tool. However, 3DRA 
has not become a standard imaging procedure in pediatric cardiology up to now. Effort and advantage 
seems to be unbalanced, but new less invasive techniques may upgrade this method in future.
Congenital heart disease (CHD) is often associated with complex anatomical anomalies. High-resolution imag-
ing modalities are particularly helpful in this context1. During the last decade, the three-dimensional rotational 
angiography (3DRA) has emerged as a new facility for diagnostic and interventional procedures. The 3DRA is 
performed by a C-arm of the angiography-system equipped with a flat detector. It generates a 3D volume data 
set from a single C-arm rotation (at least 180° plus fan angle) around the patient during a continuous injection of 
contrast dye. It provides a precise view of cardiovascular and surrounding structures in various projections2 and 
can be used for 3D-guidance additionally3,4.
The 3DRA, also called flat detector computed tomography (FD-CT) or cone beam CT, was developed in the 
1990s and initially used for neuroradiology procedures. In 1997, Fahrig et al. published the first experience with 
this technique in the setting of neuroendovascular therapy procedures5. Furthermore, the benefit of this imaging 
tool was described for coil embolization of cerebral aneurysm, cardiac electrophysiology, valve replacement and 
liver tumor embolization6–9.
In 2010, Glatz et al. presented the first systematic analysis of 3DRA in the cardiac catheterization laboratory 
for patients with CHD10. The 3DRA allows a real-time viewing of the native angiography (native 3DRA) as well 
as post processed precise 3D model (reconstructed 3DRA) for diagnostic purpose. Additionally, 3D navigation in 
catheter-based interventions is feasible. Nowadays, CT-like soft tissue image quality is acquirable due to contin-
uous development of this technique2.
Until now, 3DRA has not become a standard procedure in the pediatric cardiac catheterization laboratory. 
This technique requires X-ray, a high volume contrast injection and is acquired intraprocedural with obstruc-
tion of the continuous course of catheterization. Due to the limited temporal resolution, procedures like rapid 
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pacing, breath-holdings or bolus injection of adenosine are in use to optimize image quality with possible side 
effects2,3,10–20. Therefore, we evaluated usability and possible benefit of 3DRA in patients with CHD, particularly 
with regard to other less invasive technologies that may replace this technique in the future.
Material and Methods
Study design and patients. This study was conducted in accordance with the Declaration of Helsinki and 
the ethics commission of the Friedrich-Alexander-University Erlangen-Nuremberg (Re.-No. 4477) approved the 
experimental protocol. All patients were complying with our institutional requirements for cardiac catheteriza-
tion. Parental written informed consent for cardiac catheterization and contrast-enhanced imaging was obtained 
for all children.
All patients with CHD who underwent a 3DRA in our pediatric cardiac cath lab between January 2010 and 
May 2019 were retrospectively included. All interventional and diagnostic 3DRAs were analyzed for radiation 
exposure, contrast consumption and particularly, the diagnostic advantage of the 3D-models achieved by post 
processing over the native 3D angiography.
Rotational angiography. All examinations were performed on a biplane angiography system with two 20 
× 20 cm2 flat-panel detectors (Axiom Artis, Siemens Medical Solutions, Forchheim, Germany). Image acquisition 
was executed with two different settings. The so-called diagnostic program (5sDRc) was used with 30 frames per 
second (f/s), a dose of 0.36 µGy per image, 5 s scanning time, with a fixed tube voltage of 90 kV and automatically 
adapted tube current. In contrast, with the low-dose program (5sDR-L) the tube voltage was reduced to 70 kV, a 
0.2 mm copper filter was applied and the dose per image was only 0.1 µGy. The frames per second and scanning 
time were identical in both programs. The anti-scatter grid was removed in patients with a weight lower than 
20 kg.
The native 3DRA is a 5 s angiography recorded continuously while moving the c-arm 180 degrees around 
the patient. This data is post-processed automatically by a workstation to create a 3D model from the prior angi-
ography (Leonardo DynaCT, InSpace 3D software, Siemens Medical Solutions). It is commercially available. In 
a further step, the 3D-model was analyzed and modified by a pediatric cardiologist immediately after acquisi-
tion. This implies adapting the lightning and opacity settings and cropping of obstructing structures like bones. 
Cross-sectional images were created with 0.4 mm thickness in a 500 × 500 matrix format. In case of interventions, 
a 3D model in volume rendering format (VRT) was always merged with the real-time fluoroscopic image of the 
“A” camera (2D-3D-Registation)2. The radiation dose was measured as dose-area product (DAP) in the collimator 
housing, independent from distance of the patient. The contrast agent Imeron® 350 (350 mg iodine/ml; Bracco 
Imaging Deutschland GmbH) was diluted in the ratio 1:1 with saline. The places of injection and acquisition time 
were dependent on the volume of interest (VOI) and hemodynamics4. The diagnostic value of the reconstructed 
3D model (reconstructed 3DRA) in comparison to the prior native 3DRA, which is the base of the 3D-model, was 
rated directly post catheterization by the operator. A 3-point scale was used: “Superior”, if the 3D-model showed 
additional information to native 3DRA, “equal” if it added no supplementary information and “minor”, if it was 
misleading and not helpful due to artefacts.
Statistical analysis. Descriptive statistics contain continuous variables. They are expressed as a median 
Q2 with an interquartile range (Q1-Q3), in which Q1 was the 25th percentile and Q3 was the 75th percentile, 
or mean ± standard deviation (SD). Categorical variables are presented as numbers and percentages. Statistical 
analysis was performed using StatPlus (Version v6, AnalystSoft Inc.).
Research involving human and animal participants. All procedures performed in this study involving 
human participants were in accordance with the ethical standards of the institutional and/or national research 
committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This 
article does not contain any studies with animals performed by any of the authors.
Informed consent. Informed consent was obtained from all individual participants included in the study for 
the primary imaging. This study was positively evaluated by the institutional ethic commission (Re.-No. 4477).
Results
During the ten years study period, a total of 3526 cardiac catheterizations were performed at our institution. We 
investigated all patients (n = 507) who underwent a diagnostic or interventional 3DRA in this group. In total, 872 
3DRAs were performed in 829 examinations. The percentage of 3DRAs in comparison to all catheterizations is 
shown in Fig. 1.
67.2% (585/872) of 3DRAs were conducted during interventional procedures and 32.9% (287/872) during 
diagnostic procedures (Fig. 1). The most common CHD were pulmonary atresia with ventricular septal defect in 
12.8% (110/821), aortic coarctation in 12.5% (112/872), double outlet right ventricle in 7.9% (69/872), univen-
tricular hearts after Glenn procedure in 12.4% (108/872) and with Fontan circulation in 5.5% (48/872).
The overall number of 3DRAs peaked in 2014 (n = 145). At the same time, the proportion of low dose 3DRAs 
(5sDR-L) increased with being our standard acquisition program since 2016. The percentage of 3DRAs in relation 
to total number of catheterizations was highest in 2013 with 39.4% and decreased continuously to 7.2% in 2019.
The patients had a median age of 3.2 years (0.64–12.46 years) and a median weight of 14.2 kg (7.4–42.5 kg). 
The demographics of patients and procedural data are shown in Table 1. In 10% of the cases (87/872), the patients 
were mechanically ventilated during the investigation. No adverse events directly related to the angiography were 
observed.
The median amount of contrast agent used for a 3DRA in both protocols was 1.6 ml/kg (0.9–2.07 ml/kg); 
the median amount of contrast for the entire catheterization was 3.5 ml/kg (2.15–6.1 ml/kg), see Table 2. A 
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Figure 1. The figure shows the number of all catheterizations and percentage of 3DRAs overall and in 
interventional procedures in our institution between January 2010 and May 2019. Additionally, the number 
of all 3D-overlay-procedures, either 3DRA-based or by 2D-3D-registration with models from MRI or CT. The 
drop of 3DRA in 2014 was caused by an introduction of a new 3D-guidance technique that is based on MRI and 
CT-datasets.
Parameter Result
Number of patients 507
Male (%) 318 (62.7)
Age (years) 3.5 (0.64–12.46)
Height (cm) 96.0 (69.0–15.0)
Weight (kg) 14.2 (7.4–42.5)
Body surface area (m2) 0.6 (0.37–1.34)
Number of catheterizations 829
Number of 3DRAs 872
Diagnostic catheterizations (%) 287 (32.9)
Interventional catheterizations (%) 585 (67.1)
5sDRc (%) 412 (47.2)
5sDR-L (%) 460 (52.8)
3DRA dose-area product (µGym2) 54.1 (21.7–147.47)
Total dose-area product (µGym2) 240.3 (97.57–692.08)
3DRA contrast-medium/wt (ml/kg) 1.6 (0.9–2.07)
Total contrast-medium/wt (ml/kg) 3.5 (2.15–6.1)
Table 1. Demographic and procedural data, median (interquartile range), number (percentage of total).
Diagnostic protocol - 
5sDRc (n = 412)
Low-dose protocol - 
5sDR-L (n = 460)
Median 1.8 (1.18–2.16) 1.4 (0.77–1.93)
Mean 1.76 ± 0.84 1.45 ± 0.76
Minimum 0.32 0.22
Maximum 5.77 4.03
Table 2. Used contrast medium in our study cohort for 3DRA in ml/kg, median (interquartile range), mean ± 
SD.
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continuous administration of contrast agent proximal to VOI facilitates high-resolution images. In most cases, 
we used a delay time of 1 s to visualize the aorta or 2 s for the pulmonary veins by injection into the pulmonary 
artery (PA).
Overall, median DAP to acquire a 3DRA was 54.1 µGym2 (21.7–147.47 µGym2). Between 2010 and 2015, the 
diagnostic program (5sDRc) was used in 412 cases with a median DAP of 73.1 µGym2 (48.41–214.63 µGym2). 
Between 2011 and 2018, we utilized the low-dose program (5sDR-L) in 460 cases and the median DAP was even 
lower with 24.51 µGym2 (13.23–97.15 µGym2), see Table 3.
On the 3-point scale, we rated the diagnostic value of the reconstructed 3DRA in 94% (819/872) as superior, 
5.5% (48/872) as equal and 0.6% (5/872) as inferior to the native 3DRA.
Discussion
Our systematic analysis of 872 3DRAs shows a conclusive diagnostic value of 3DRA with further substantial 
advantage of 3D-navigation. To our knowledge, this retrospective single center study is the largest cohort of pedi-
atric cardiology patients in whom 3DRA was applied.
The continuous improvement of 3DRA facilitated the implementation in the pediatric catheterization labora-
tory2,10. This applies especially to certain extracardiac pathologies such as Fontan circulation, aortic arch and pul-
monary artery anomalies2,4,21. Due to the introduction of a new 3D-guidance modality22, the number of 3DRAs 
decreased continuously since 2014 at our institution. The formation of native 3D angiographies and subsequent 
3D-reconstruction seem to be replaceable by other pre-interventional 3D-imaging technologies. This reflects 
the importance of 3D-imaging and accurate 3D-guidance independent of the matrix used for creation of the 3D 
models. Figure 1 illustrates the gain of 3D-overlay in our cath lab despite fewer applications of 3DRA.
Diagnostic utility and image quality. The three-dimensional model derived from 3DRA demonstrates 
the vascular configuration and the spatial relationship between cardiovascular structures and surrounding tis-
sue very precisely. This becomes particularly clear as we rated the diagnostic value in 94% (819/872) superior to 
the native 3D angiography. This was due to the reconstructed 3D-models enabling the visualization of anatomy 
and complex spatial relationships from any desired angle of view. Additionally, comparative measurements of 
vessel diameters in 3DRAs and biplane angiographies show a high accuracy in settings with a low blood flow 
(e.g. Cavopulmonary connections) as well as in regions with a more pulsatile flow (e.g. aorta)3,15,23. Image quality 
depends on various factors that can mutually influence each other. The poor temporal acquisition requires a con-
stant injection of contrast dye in the region of interest over seconds with a suitable delay. Moreover, heart move-
ment, spontaneous breathing and the long acquisition time of at least 5 s may result in artefacts with an inferior 
image quality2,10,12,18. To reduce these artefacts, breathholding maneuvers in mechanical ventilated patients are 
common2,3,10–12,14–20. Rapid pacing or injection of adenosine is in use to manipulate heart rate2,3,13,16,18–20. Another 
possibility to achieve a higher image quality is to avoid rapid drainage of the contrast medium by balloon occlu-
sion of the run-off vessel2. All these procedures are invasive, with possible side effects. In our institution, we only 
use breathholding in mechanically ventilated patients.
Radiation. Our study showed a median DAP of 54.1 µGym2 (21.7–147.5 µGym2) for all 3DRAs (n = 872). For 
the last five years, we mainly used the low-dose program (5sDR-L) (n = 460). This resulted in an even lower DAP 
with a median of 24.5 µGym2 (13.2–97.2 µGym2). Compared to our previous studies2,4, we were able to maintain 
high quality standard of the images with a significant reduction of radiation dose at the same time. Our results 
compare well with the study from Aldoss et al., which reported a median DAP of 72.3 µGym212. Truong et al. pub-
lished similar low radiation doses (DAP = 85 µGym2)17. Conversely, the study of Haddad et al. showed a higher 
median DAP with 278.0 µGym2. This may have resulted from a higher median age (10.2 years) and median weight 
of the patients (39.8 kg)20. A recent study from Goreczny et al. presented very high values for both conventional 
biplane guidance and 3DRA, with significant higher DAP for conventional biplane guidance compared with 
3DRA (17745.9 µGym2 vs. 10832.3 µGym2). This high DAP for 3DRA of 10832.3 µGym2 may as well be due to the 
high median weight of patients (49.3 kg). The small number of patients (n = 6) limits the validity11. Berman et al. 
reported about a DAP of 306.0 µGycm2 when using 3DRA, which was almost twice that of a biplane angiogram 
with a DAP of 159.0 µGycm2 3. Manica et al. have also shown a higher radiation dose with a DAP of 713 µGym2 
(n = 9) for a 3DRA versus a conventional biplane angiography with 81 µGym2 24. However, this large difference 
was only significant in patients with less than 45 kg bodyweight.
An important factor to assess possible radiation sequels is the effective dose (ED), which considers the indi-
vidual radiosensitivity of organs25. Truong et al. described a median ED of 0.16 mSv for 3DRA and compared it to 
the results of a study population undergoing a pediatric chest CT with an ED of 2.0 mSv for a low-dose protocol26. 
Peters et al. focused on ED during 3DRA in children. The median ED was 1.6 mSv (0.7–4.9 mSv) and was calcu-
lated with the Monte Carlo method. This work refers to findings of Wielandt et al. This group estimated a mean 
ED of 6.6 ± 1.8 mSV in computer simulated phantoms (PCXMC)9. In a phantom study at our facility, ED was 
Diagnostic protocol - 
5sDRc (n = 412)
Low-dose protocol - 
5sDR-L (n = 460)
Median 73.1 (48.41–214.63) 24.51 (13.23–97.15)
Mean 193.67 ± 263.66 81.17 ± 115.31
Minimum 11.45 1.6
Maximum 1578.3 735.57
Table 3. Dose area product in µGym2 of 3DRA in our study cohort, median (interquartile range), mean ± SD.
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calculated in three different anthropomorphic phantoms with a diagnostic and a low-dosage program resulting 
in an ED for 3DRA lower than 1 mSv27.
Contrast dye. The median amount for a single 3DRA was 1.6 ml/kg (0.9–2.1 ml/kg) in our study. The con-
centration and amount of contrast dye depends on the anatomic region and hemodynamics. These findings are 
comparable to those in the reviewed literature. Besides the risk of adverse reactions to iodine carries, the bio-
logical effect of radiation is rising with a higher amount of contrast28. The great advantage of 3DRA is the fact 
that one single injection is sufficient to detect any lesion that may be undiagnosed with a conventional biplane 
angiography3. Using 3D-guidance, repeated contrast injections for positioning control can be avoided, which may 
results in an overall reduction of contrast dye4,23. Recently, a study from Goreczny et al. compared the 3D naviga-
tion modalities: traditional 2D guidance, 3DRA and new software (VesselNavigator) for 2D-3D image fusion in 
patients who underwent a percutaneous pulmonary valve implantation. They demonstrated a significantly lower 
contrast use for the VesselNavigator guidance (n = 7) in comparison to 3DRA guidance (1.5 ml/kg vs. 4.7 ml/kg; 
p = 0.04), but there was no significant difference between the 3DRA guidance and the 2D guidance (p = 0.57)11.
Utility of 3DRA and alternatives. The clinical benefit of 3DRA is the generation of high-resolution 
images, which facilitate understanding and visualization of complex CHD10. Furthermore, 3D guidance is a help-
ful tool in catheter-based interventions as it overcomes specific limitations of conventional biplane angiography 
(Fig. 2)4,10,11.
Patients with complex CHD often undergo various pre-interventional or pre-surgical imaging modalities. 
Echocardiography is the gold standard in most straightforward cases. Nevertheless, specific issues may be not 
answered due to a bad acoustic window or difficult tortuous vascular structures29. Imaging methods such as CT or 
MRI have experienced a rapid technical and scientific development in the last decade. Simultaneous to the newly 
emerging 3DRA, new modalities for CT as the multidetector computed tomography (MDCT) or dual-source 
computed tomography (DSCT) were established. MDCT has a high spatial and temporal resolution and demon-
strates a diagnostic utility that may replace invasive diagnostic methods30. The DSCT convinces with a fast sub-
second scanning time for the whole thorax acquisition and less radiation exposure (ED less than 0.5 mSv)31. A 
quick generation of 3D data sets by DSCT provides precise anatomical information, making surgical planning 
easier and more successful31,32.
Figure 2. Rotational angiography in the right ventricle in a 3-month-old boy with Hypoplastic left heart 
syndrome. Overlay in volume rendering format on the fluoroscopic image for 3D guidance. The 3D model may 
obstruct tiny structures like wires and devices.
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Recent innovations of 3D-guidance allow 2D-3D fusion of imaging data in different formats without needing 
images obtained by intraprocedural 3DRA (Figs. 3 and 4). This means further reduction of contrast medium and 
radiation dose. With these new and innovative imaging tools at hand, some authors concluded that diagnostic 
3DRA is negligible and outdated for primary diagnosis and 3D-guidance22,31. Additionally, pre-procedural data 
sets enable an efficient planning of interventional procedures in a timely manner. This is our experience as well 
and these new developments are leading to a continuous decline of 3DRA in our cath lab since introduction of the 
new guiding- technologies (Fig. 1).
3DRA is an invasive imaging tool that requires adequate sedation and an vascular access which involves cer-
tain risks such as infection, vessel damage and hemorrhage33. Poorer resolution in comparison to DSCT is mainly 
caused by the long acquisition time. Moreover, the generated 3D model from 3DRA has to be processed and vis-
ualized in a proper way, which is mostly done immediately after acquisition during cardiac catheterization. This 
is time consuming, interrupts the course of catheterization and needs special trained staff to adapt the imaging 
data. From our perspective, 3DRA is still very helpful in unplanned situations during cardiac catheterizations 
when complex anatomy has to be visualized immediately and accurately as well as in emergencies2. A recent study 
from our faculty demonstrated a new facility of 3D guidance with a 2D-3D registration from previous MRI or CT 
data sets. We used segmented imaging data in a stereolithographic format (Figs. 3 and 4). That way, we were able 
to generate superior image quality with much better visibility of catheters and devices compared to traditional 
image-overlay in a volume rendering format22. The possibility to integrate 3D-images from less invasive imaging 
modalities with pre-operative acquisition reduced the number of 3DRA in our institution significantly. At the 
beginning, 3DRA being a unique imaging modality for interventional 3D-guidance, we used it in nearly 40% of 
all catheterizations. Nowadays, it is only used in unplanned catheterization with no existing pre-interventional 
imaging data or in catheterization with invasive testing. One example is the simultaneous ballooning of the pul-
monary conduit and 3DRA of the aortic root to rule out potential coronary compression before transcatheter 
pulmonary valve replacement.
Figure 3. 3D-guidance for stenting the arterial duct in a newborn with Hypoplastic left heart syndrome. Basic 
dataset was a 3rd generation dual source –CT, reconstructed in stereolithographic format. Overlay on both 
cameras of the biplan angiography machine, shown is the image of the b-camera. The fine delineated model 
does not obstruct the view on catheters and devices. Color-code light green: ductus arteriosus; red: aorta; violet: 
right ventricle; light blue: pulmonary artery.
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conclusion
3D-imaging improves diagnostic possibilities and quality compared to a native 3DRA which consists out of 
2D-projection images. Reconstructed 3DRA are very helpful and well utilizable for 3D-guiding in complex inter-
ventions in congenital heart disease. Until now, 3DRA has not become a standard process for diagnostic or inter-
ventional procedures in the pediatric cardiology cath lab. There are various limitations of this technique e.g. the 
complexity of application, the absence of standardization and the need of special trained staff for this imaging 
technique.
MRI and DSCT-scans have better temporal resolution compared to 3D models based on 3DRA. Additionally, 
MRI- and DSCT-scans can be used for catheter-guidance with new multimodality and overlay registration tech-
niques as well. Thus, these less invasive procedures should be preferred in the daily routine, if available. However, 
the native rotational angiography includes important flow information with high temporal and spatial resolution. 
In the hands of an experienced investigator, the immediate availability of these information during the dynamic 
process of interventional catheterization of complex congenital heart disease, gives 3DRA a great importance in 
selected cases. The lack of standardization is still an issue.
Limitations
A limitation is the retrospective nature of our study. The patient collective was a heterogeneous cohort.
The present work was performed in fulfillment of the requirements for obtaining the degree “Dr. med.” at the 
Friedrich-Alexander-University Erlangen-Nuremberg.
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